The Federal Trade Commission (FTC) is asking for information from wholesalers and other middlemen in the pharmaceutical supply chain in an investigation into worsening shortages of generic medicines.
The individuals or companies within that complicated supply chain are what MCCPDC calls "the middlemen," namely pharmacy benefit managers (PBM) or group purchasing organisations (GPOs), who can be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback